Pfizer Inc.
Explore Pfizer Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Pfizer Inc.
Explore Pfizer Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$58.5B
▼ 41.7% vs FY2022 ($100.3B)
Source: Annual report / company filing
Pfizer Inc. reported $58.5B in revenue for fiscal year 2023. This represents a decline of 41.7% compared to the 2022 figure of $100.3B. In 2024, revenue increased to $63.6B.
Revenue fell 41.7% to 58.5 billion dollars in 2023 as COVID demand collapsed and governments stopped stockpiling vaccines and antivirals, though it still topped the pre-pandemic baseline.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $62.6B | — | -1.6% |
| FY2024 | $63.6B | $8.0B | +8.7% |
| FY2023 | $58.5B | — | -41.7% |
| FY2022 | $100.3B | — | +23.4% |
| FY2021 | $81.3B | — | +94.0% |
| FY2020 | $41.9B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.